Primobolan 100 SUPERHUMAN PHARMA®
Current Lot: R136Q0
CAS RN® 70024-90-7
Harmonized System (HS) Code *: 350290
UN No: N/A
NDC No: N/A
Molecular Formula: C2936H4624N786O889S41
Container Type: VIAL
Base Control Substance (substance %): N/A
DESCRIPTION:
Overview
Primobolan 100 (Methenolone Enanthate) is indicated for the treatment of aplastic anemia, breast cancer, postmenopausal osteoporosis and sarcopenia (the loss of muscle as correlated with aging). Also, the drug is utilized to treat individuals suffering from conditions in which muscle wasting and severe weight loss is a symptom, and as an immunostimulant for individuals fighting infections. Primobolan 100 is manufactured as methenolone enanthate 100mg/ml injections that contain 100mg of methenolone enanthate and excipients.
Methenolone Enanthate Mechanism of Action
Methenolone enanthate is an ester of methenolone, the active form of the drug. Methenolone acts on androgen receptors to exert some of its effects. It has moderate anabolic properties and weak androgenic properties. However, it also exerts some of its effect on the bone marrow which makes it suitable for the treatment of anemia. Its mechanism of action does not produce estrogenic side effects.
Methenolone Acetate Dosage
100mg intramuscular injection taken.
Methenolone Enanthate Side effects
Side effects include masculinization in women, acne, increased sexual libido, and changes in voice, reversible hypogonadism.
Methenolone Enanthate Interactions
Betamethasone phosphate ciclesonide, budesonide.
✓ Methenolone Enanthate . . . . 100mg
✓ Excipients . . . . . . . . . . . . . . . . . . . . . q.s